{"id":"https://openalex.org/W2004115135","doi":"https://doi.org/10.1016/j.ejphar.2009.07.004","title":"Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models","display_name":"Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models","publication_year":2009,"publication_date":"2009-07-18","ids":{"openalex":"https://openalex.org/W2004115135","doi":"https://doi.org/10.1016/j.ejphar.2009.07.004","mag":"2004115135","pmid":"https://pubmed.ncbi.nlm.nih.gov/19616540"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejphar.2009.07.004","doi":"https://doi.org/10.1016/j.ejphar.2009.07.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2009.07.004","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038187639","display_name":"Marc Issandou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Marc Issandou","raw_affiliation_strings":["GlaxoSmithKline, Les Ulis Cedex, France. marc.issandou@GSK.com","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Les Ulis Cedex, France. marc.issandou@GSK.com","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073815852","display_name":"Anne Bouillot","orcid":"https://orcid.org/0000-0002-7433-5714","observed_orcids":["https://orcid.org/0000-0002-7433-5714"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Bouillot","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071251525","display_name":"Jean-Marie G. Brusq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Marie Brusq","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108217175","display_name":"Marie-Claire Forest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Claire Forest","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003600002","display_name":"Didier Grillot","orcid":"https://orcid.org/0000-0002-0274-6514","observed_orcids":["https://orcid.org/0000-0002-0274-6514"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Didier Grillot","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021670823","display_name":"Rapha\u00eblle Guillard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Raphaelle Guillard","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014280260","display_name":"Sandrine Martin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sandrine Martin","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068238465","display_name":"Christelle Michiels","orcid":"https://orcid.org/0000-0002-7193-5642","observed_orcids":["https://orcid.org/0000-0002-7193-5642"]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christelle Michiels","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002488769","display_name":"Thierry Sulpice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090932","display_name":"Physiogenex (France)","ror":"https://ror.org/00attk912","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210090932"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thierry Sulpice","raw_affiliation_strings":["Physiogenex S.A.S, Prologue Biotech, BP28262, 31682 Labege-Innopole Cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physiogenex S.A.S, Prologue Biotech, BP28262, 31682 Labege-Innopole Cedex, France","institution_ids":["https://openalex.org/I4210090932"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063898060","display_name":"Alain Daugan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101023","display_name":"GlaxoSmithKline (France)","ror":"https://ror.org/00z1h3j87","country_code":"FR","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210101023"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Alain Daugan","raw_affiliation_strings":["GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, 25 avenue du Quebec, 91951 Les Ulis Cedex, France","institution_ids":["https://openalex.org/I4210101023"]},{"raw_affiliation_string":"GlaxoSmithKline, 25 Avenue du Qu\u00e9bec, 91951 Les Ulis cedex, France","institution_ids":["https://openalex.org/I4210101023"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5038187639"],"corresponding_institution_ids":["https://openalex.org/I4210101023"],"apc_list":{"value":3230,"currency":"USD","value_usd":3230},"apc_paid":null,"fwci":3.6642,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.93416636,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"618","issue":"1-3","first_page":"28","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":0.6157000064849854,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":0.6157000064849854,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.15520000457763672,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.06019999831914902,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/stearoyl-coa-desaturase-1","display_name":"stearoyl-CoA desaturase 1","score":0.9470000267028809},{"id":"https://openalex.org/keywords/scd1-inhibition","display_name":"SCD1 inhibition","score":0.9269999861717224},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9359999895095825},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hepatic-lipid-metabolism","display_name":"hepatic lipid metabolism","score":0.7509999871253967},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.8130000233650208},{"id":"https://openalex.org/keywords/diet-induced-obesity","display_name":"diet-induced obesity","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hyperinsulinemic-euglycemic-clamp","display_name":"hyperinsulinemic-euglycemic clamp","score":0.8730000257492065}],"concepts":[{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.8082611560821533},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7273498773574829},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7180687189102173},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6870534420013428},{"id":"https://openalex.org/C2908932551","wikidata":"https://www.wikidata.org/wiki/Q14878272","display_name":"Stearoyl-CoA Desaturase","level":4,"score":0.6810404062271118},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.635222852230072},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5643758773803711},{"id":"https://openalex.org/C2778808658","wikidata":"https://www.wikidata.org/wiki/Q2975183","display_name":"Glucose clamp technique","level":5,"score":0.5251426696777344},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5198659896850586},{"id":"https://openalex.org/C2776941171","wikidata":"https://www.wikidata.org/wiki/Q900209","display_name":"Fatty acid synthesis","level":3,"score":0.41592690348625183},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33427295088768005},{"id":"https://openalex.org/C3017594256","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin sensitivity","level":4,"score":0.3218306303024292},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31321725249290466},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.2259872555732727},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15566718578338623},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08063486218452454},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0617716908454895}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004032","descriptor_name":"Diet","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005947","descriptor_name":"Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013230","descriptor_name":"Stearoyl-CoA Desaturase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejphar.2009.07.004","doi":"https://doi.org/10.1016/j.ejphar.2009.07.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejphar.2009.07.004","pdf_url":null,"source":{"id":"https://openalex.org/S187816532","display_name":"European Journal of Pharmacology","issn_l":"0014-2999","issn":["0014-2999","1879-0712"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:19616540","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19616540","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9074000120162964,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1927710737","https://openalex.org/W1955389669","https://openalex.org/W1967000078","https://openalex.org/W1967457116","https://openalex.org/W1971349753","https://openalex.org/W1980244201","https://openalex.org/W1981478386","https://openalex.org/W1984985876","https://openalex.org/W1987553556","https://openalex.org/W1990821846","https://openalex.org/W1997085730","https://openalex.org/W2000136948","https://openalex.org/W2001491969","https://openalex.org/W2006611752","https://openalex.org/W2018621965","https://openalex.org/W2034337124","https://openalex.org/W2037481248","https://openalex.org/W2045612646","https://openalex.org/W2046805657","https://openalex.org/W2055968479","https://openalex.org/W2063086702","https://openalex.org/W2064553686","https://openalex.org/W2083511523","https://openalex.org/W2098260346","https://openalex.org/W2100481760","https://openalex.org/W2102207361","https://openalex.org/W2123521914","https://openalex.org/W2129050532","https://openalex.org/W2136014653","https://openalex.org/W2138202978","https://openalex.org/W2138842915","https://openalex.org/W2146433346","https://openalex.org/W2162692698","https://openalex.org/W2164514101","https://openalex.org/W2165912352","https://openalex.org/W2166190002","https://openalex.org/W2185000122","https://openalex.org/W4285719527","https://openalex.org/W6686541822"],"related_works":["https://openalex.org/W2081324116","https://openalex.org/W2037022118","https://openalex.org/W2165912352","https://openalex.org/W2073346921","https://openalex.org/W2061295569","https://openalex.org/W2141610820","https://openalex.org/W573179140","https://openalex.org/W1982233059","https://openalex.org/W7100083057","https://openalex.org/W2150058127"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}